Indications for Balloon Mitral Valvotomy (BMV) in Mitral Stenosis
BMV is the treatment of choice for symptomatic patients with moderate-to-severe mitral stenosis (valve area ≤1.5 cm²) who have favorable valve morphology, no left atrial thrombus, and less than moderate mitral regurgitation. 1, 2
Class I Indications (Strongest Recommendations)
Symptomatic Patients
- NYHA Class II-IV symptoms with severe MS (valve area ≤1.5 cm²) AND favorable valve characteristics 2
- Must exclude left atrial thrombus and moderate-to-severe MR before proceeding
- Favorable characteristics include: echo score ≤8, absence of heavy calcification, pliable valve leaflets, minimal subvalvular fusion 3
Asymptomatic Patients with High-Risk Features
BMV is indicated for asymptomatic patients with severe MS (valve area ≤1.5 cm²) and favorable morphology who have:
- Pulmonary hypertension: PA systolic pressure >50 mmHg at rest or >60 mmHg with exercise 2, 4
- This prevents irreversible pulmonary vascular changes and RV dysfunction 1
Class IIa Indications (Reasonable to Perform)
High Surgical Risk Patients
- Symptomatic patients (NYHA III-IV) with contraindication or high surgical risk 3
- Can be performed even with suboptimal valve anatomy if surgery is not an option 2
Unfavorable Anatomy with Good Clinical Profile
- Symptomatic patients with mild-to-moderate calcification or subvalvular involvement but otherwise favorable clinical characteristics 3
- Particularly beneficial in young patients where surgery would require valve replacement
Class IIb Indications (May Be Considered)
Asymptomatic Patients with Specific Risk Factors
BMV may be considered in asymptomatic patients with severe MS and favorable morphology who have:
- New-onset atrial fibrillation (especially if rate control is difficult) 1
- Previous history of systemic embolism 3
- Dense spontaneous echo contrast in left atrium 3
- Need for major non-cardiac surgery 3
- Desire for pregnancy 3
Symptomatic Patients with Larger Valve Areas
- Valve area >1.5 cm² but <2.0 cm² IF hemodynamically significant MS demonstrated by:
Very Severe MS
- Asymptomatic patients with very severe MS (valve area ≤1.0 cm²) and favorable morphology 1
- Intervention before severe symptoms develops better outcomes due to less valve calcification and lower pulmonary pressures
Severely Symptomatic with Suboptimal Anatomy
- NYHA Class III-IV with valve area ≤1.5 cm² who have Wilkins score >8 but are not surgical candidates 1
- Success rate is lower (42% achieve optimal outcome) but may provide palliation 1
Absolute Contraindications (Class III)
Do NOT perform BMV in patients with:
- Moderate-to-severe mitral regurgitation 2, 4
- Left atrial thrombus (standard contraindication, though specialized centers report success with modified techniques in selected cases) 2, 4
- Mild MS (valve area >1.5 cm² without exercise-induced hemodynamic significance) 2
Key Clinical Decision Points
Favorable Characteristics for BMV
Anatomic factors (echo score ≤8):
- Pliable, non-calcified leaflets
- Minimal subvalvular fusion
- Absence of commissural calcification on fluoroscopy (Cormier score <3) 3
Clinical factors favoring success:
- Younger age
- Sinus rhythm (though AF not absolute contraindication)
- No prior commissurotomy
- NYHA Class II-III (not Class IV)
- Absence of severe pulmonary hypertension 3
Unfavorable Characteristics
Presence of several of these increases risk:
- Echo score >8
- Heavy calcification
- Severe subvalvular disease
- Very small valve area
- Severe tricuspid regurgitation
- NYHA Class IV
- Severe pulmonary hypertension
- History of prior commissurotomy 3
Expected Outcomes and Complications
Success rates: 80-95% achieve valve area >1.5 cm² with doubling of initial area 2, 5
Major complications (experienced centers):
- Procedural mortality: 0.5-2% 3
- Severe MR: 2-10% 3
- Cardiac tamponade: 0.5-4% 3
- Thromboembolism: 0.5-3% 3
- Emergency surgery needed: <1% 3
Special Populations
Pregnancy
- BMV is reasonable for severe symptomatic MS refractory to medical therapy during pregnancy 6
- Use Inoue technique with total abdominal/pelvic shielding to minimize fetal radiation exposure
- Perform in second trimester when possible
Critically Ill Patients
- Emergent BMV can be performed in patients with cardiogenic shock, cardiac arrest, or refractory pulmonary edema 7
- In-hospital mortality is 35%, but survivors have excellent outcomes
- Predictors of mortality: echo score ≥8, PA pressure ≥65 mmHg, cardiac output ≤3.15 L/min
Common Pitfalls to Avoid
- Don't delay intervention until severe calcification develops—outcomes are significantly better with pliable valves
- Don't ignore exercise testing in symptomatic patients with valve area 1.5-2.0 cm²—exercise hemodynamics may reveal true severity
- Don't perform BMV without transesophageal echo to exclude LA thrombus
- Don't assume all asymptomatic patients should wait—very severe MS (≤1.0 cm²) or pulmonary hypertension warrant intervention
- Ensure procedure is performed at experienced centers—outcomes are operator-dependent with steep learning curve 2